EVAX Forex-Nachrichten
Evaxion Biotech Gets FDA Approval To Proceed With Clinical Phase 2b Study For EVX-01
Biotech company Evaxion Biotech A/S (EVAX) announced Tuesday that the U.S. Food and Drug Administration or FDA, determined that the Company may proceed with its Phase 2b clinical trial of EVX-01.
RTTNews
|
vor 764 Tagen
